Tokyo Tape
Sign in
← Muromachi Chemicals

Quarterly report · Q3

4885.TEDINET S100QLE5
Period2022-06-01 → 2023-02-28
Filed2023-04-14
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 38
MetricValuePeriodScopeSource row
Revenue¥4.6bn2022-06-01 → 2023-02-28StandaloneNet sales
Revenue¥5.7bn2021-06-01 → 2022-05-31StandaloneNet sales (5-year summary)
Revenue¥4.1bn2021-06-01 → 2022-02-28StandaloneNet sales
Operating income¥325m2022-06-01 → 2023-02-28StandaloneOperating income
Operating income¥355m2021-06-01 → 2022-02-28StandaloneOperating income
Ordinary income¥309m2022-06-01 → 2023-02-28StandaloneOrdinary income
Ordinary income¥423m2021-06-01 → 2022-05-31StandaloneOrdinary income loss (5-year summary)
Ordinary income¥355m2021-06-01 → 2022-02-28StandaloneOrdinary income
Profit before tax¥309m2022-06-01 → 2023-02-28StandaloneIncome before income taxes
Profit before tax¥354m2021-06-01 → 2022-02-28StandaloneIncome before income taxes
Net income¥230m2022-06-01 → 2023-02-28StandaloneProfit loss
Net income¥456m2021-06-01 → 2022-05-31StandaloneNet income loss (5-year summary)
Net income¥300m2021-06-01 → 2022-02-28StandaloneProfit loss
Total assets¥5.0bnat 2023-02-28StandaloneAssets
Total assets¥4.8bnat 2022-05-31StandaloneAssets
Total assets¥4.6bnat 2022-02-28StandaloneTotal assets (5-year summary)
Total liabilities¥3.1bnat 2023-02-28StandaloneLiabilities
Total liabilities¥3.1bnat 2022-05-31StandaloneLiabilities
Net assets / equity¥1.9bnat 2023-02-28StandaloneNet assets
Net assets / equity¥1.7bnat 2022-05-31StandaloneNet assets
Net assets / equity¥1.6bnat 2022-02-28StandaloneNet assets (5-year summary)
Cash and deposits¥681mat 2023-02-28StandaloneCash and deposits
Cash and deposits¥865mat 2022-05-31StandaloneCash and deposits
EPS (basic)¥61.462022-06-01 → 2023-02-28StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥21.532022-12-01 → 2023-02-28dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥123.792021-06-01 → 2022-05-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥81.552021-06-01 → 2022-02-28StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥10.262021-12-01 → 2022-02-28dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥58.552022-06-01 → 2023-02-28StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥112.562021-06-01 → 2022-05-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥73.622021-06-01 → 2022-02-28StandaloneDiluted earnings per share (5-year summary)
Dividend per share¥192021-06-01 → 2022-05-31StandaloneDividend paid per share (5-year summary)
Equity ratio37.5%at 2023-02-28StandaloneEquity to asset ratio (5-year summary)
Equity ratio35.0%at 2022-05-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio35.2%at 2022-02-28StandaloneEquity to asset ratio (5-year summary)
Shares issued4,095,500at 2023-02-28StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2022-05-31StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2022-02-28StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentrevenue2022-06-01 → 2023-02-28¥1.5bn
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentrevenue external2022-06-01 → 2023-02-28¥1.5bn
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentsegment profit2022-06-01 → 2023-02-28−¥25m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentrevenue2022-06-01 → 2023-02-28¥528m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentrevenue external2022-06-01 → 2023-02-28¥528m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentsegment profit2022-06-01 → 2023-02-28−¥75m
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentrevenue2022-06-01 → 2023-02-28¥2.6bn
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentrevenue external2022-06-01 → 2023-02-28¥2.6bn
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentsegment profit2022-06-01 → 2023-02-28¥426m
—segment totalrevenue2022-06-01 → 2023-02-28¥4.6bn
—segment totalrevenue external2022-06-01 → 2023-02-28¥4.6bn
—segment totalsegment profit2022-06-01 → 2023-02-28¥325m
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2023-02-28¥4.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2023-02-28¥4.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2023-02-28¥325m
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentrevenue2021-06-01 → 2022-02-28¥1.4bn
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentrevenue external2021-06-01 → 2022-02-28¥1.4bn
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentsegment profit2021-06-01 → 2022-02-28−¥2m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentrevenue2021-06-01 → 2022-02-28¥668m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentrevenue external2021-06-01 → 2022-02-28¥668m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentsegment profit2021-06-01 → 2022-02-28¥22m
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentrevenue2021-06-01 → 2022-02-28¥2.0bn
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentrevenue external2021-06-01 → 2022-02-28¥2.0bn
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentsegment profit2021-06-01 → 2022-02-28¥335m
—segment totalrevenue2021-06-01 → 2022-02-28¥4.1bn
—segment totalrevenue external2021-06-01 → 2022-02-28¥4.1bn
—segment totalsegment profit2021-06-01 → 2022-02-28¥355m
Total Of Reportable Segments And Otherssegment totalrevenue2021-06-01 → 2022-02-28¥4.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-06-01 → 2022-02-28¥4.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-06-01 → 2022-02-28¥355m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 369
ItemContextValueUnit
Operating incomePrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000ChemicalProductsBusinessReportableSegmentMember-2498000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember_ReportableSegmentsMember354771000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember354771000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember354771000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000PharmaceuticalBusinessReportableSegmentMember2601224000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000HealthyFoodBusinessReportableSegmentMember528184000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000ChemicalProductsBusinessReportableSegmentMember1495196000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember4624606000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember4624606000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember4624606000JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000PharmaceuticalBusinessReportableSegmentMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000HealthyFoodBusinessReportableSegmentMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000ChemicalProductsBusinessReportableSegmentMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember－JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000PharmaceuticalBusinessReportableSegmentMember2601224000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000HealthyFoodBusinessReportableSegmentMember528184000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000ChemicalProductsBusinessReportableSegmentMember1495196000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember4624606000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember4624606000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Net salesCurrentYTDDuration_NonConsolidatedMember4624606000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000PharmaceuticalBusinessReportableSegmentMember425507000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000HealthyFoodBusinessReportableSegmentMember-74757000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E36350-000ChemicalProductsBusinessReportableSegmentMember-25340000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember325409000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember325409000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember325409000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の4の7第1項
Place of filing cover pageFilingDateInstant
Original text (Japanese)福岡財務支局長
Filing date cover pageFilingDateInstant2023-04-14
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第77期第3四半期(自　2022年12月1日　至　2023年2月28日)
Company name cover pageFilingDateInstant
Original text (Japanese)室町ケミカル株式会社
Company name in english cover pageFilingDateInstantMUROMACHI CHEMICALS INC.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　　青木　淳一
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)福岡県大牟田市新勝立町一丁目38番5
Telephone number address of registered headquarter cover pageFilingDateInstant0944-41-2131
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役　管理本部長　　井内　聡
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)福岡県大牟田市新勝立町一丁目38番5
Telephone number nearest place of contact cover pageFilingDateInstant0944-41-2131
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役　管理本部長　　井内　聡
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE36350
Fund codeFilingDateInstant－

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2022-05-31pass rounding
balance sheet identitynon_consolidated 2023-02-28pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-05-31pass
statement vs summary · net assetsnon_consolidated 2023-02-28pass
statement vs summary · revenuenon_consolidated 2021-06-01/2022-02-28pass
statement vs summary · revenuenon_consolidated 2022-06-01/2023-02-28pass
statement vs summary · total assetsnon_consolidated 2022-05-31pass
statement vs summary · total assetsnon_consolidated 2023-02-28pass